German biotech firms raised more capital in 2018 than ever before. Previously unpublished figures show, according to research by the biotechnology industry association BIO Deutschland, that more than one billion euros of venture capital and other equity investment flowed into the industry, whereby particularly large inflows of capital to two companies contributed to the good overall result.
The median salaries for various positions in the biotech industry have in some cases seen high single or double-digit increases in the past two years, according to a salary comparison study conducted by the biotech industry association BIO Deutschland.
The terms of Brexit remain unclear. German companies, with their close economic ties to the United Kingdom (UK), should therefore be prepared for the possibility of a hard Brexit.
The Health – Made in Germany export initiative kicked off the year with a new service that promotes the German biotechnology industry abroad.